Optipharm Co (XKRX:153710) Days Sales Outstanding : 21.48 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Optipharm Co Days Sales Outstanding?

Optipharm Co's average Accounts Receivable for the three months ended in Dec. 2023 was ₩1,188 Mil. Optipharm Co's Revenue for the three months ended in Dec. 2023 was ₩5,045 Mil. Hence, Optipharm Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 21.48.

The historical rank and industry rank for Optipharm Co's Days Sales Outstanding or its related term are showing as below:

XKRX:153710' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.86 Med: 28.25 Max: 37.03
Current: 23.92

During the past 11 years, Optipharm Co's highest Days Sales Outstanding was 37.03. The lowest was 23.86. And the median was 28.25.

XKRX:153710's Days Sales Outstanding is ranked better than
94.14% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.345 vs XKRX:153710: 23.92

Optipharm Co's Days Sales Outstanding declined from Dec. 2022 (21.54) to Dec. 2023 (21.48).

Optipharm Co Days Sales Outstanding Historical Data

The historical data trend for Optipharm Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optipharm Co Days Sales Outstanding Chart

Optipharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

30.74

27.52

23.86

24.22

26.19

Optipharm Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															21.54	25.39	24.01	23.08	21.48

Competitive Comparison of Optipharm Co's Days Sales Outstanding

For the Diagnostics & Research subindustry, Optipharm Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optipharm Co's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optipharm Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Optipharm Co's Days Sales Outstanding falls into.

Optipharm Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Optipharm Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1124.026	+	1368.812)	/	2 )	/	17372.568	*	365
=	1246.419					/	17372.568	*	365
=	26.19

Optipharm Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1006.574	+	1368.812)	/	2 )	/	5045.37	*	365 / 4
=	1187.693					/	5045.37	*	365 / 4
=	21.48

Optipharm Co (XKRX:153710) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Optipharm Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Optipharm Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Optipharm Co (XKRX:153710) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

6, 63 Osong, Hwaseong-eup, Heungduk-gu, Chungcheongbuk-do, Cheongju, KOR

Website

http://www.optipharm.co.kr

Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.

Optipharm Co (XKRX:153710) Headlines

No Headlines